IL176615A0 - Use of an a3 adenosine receptor agonist for the preparation of a pharmaceutical composition for treatment of multiple sclerosis and such pharmaceutical compositions - Google Patents

Use of an a3 adenosine receptor agonist for the preparation of a pharmaceutical composition for treatment of multiple sclerosis and such pharmaceutical compositions

Info

Publication number
IL176615A0
IL176615A0 IL176615A IL17661506A IL176615A0 IL 176615 A0 IL176615 A0 IL 176615A0 IL 176615 A IL176615 A IL 176615A IL 17661506 A IL17661506 A IL 17661506A IL 176615 A0 IL176615 A0 IL 176615A0
Authority
IL
Israel
Prior art keywords
preparation
treatment
multiple sclerosis
receptor agonist
adenosine receptor
Prior art date
Application number
IL176615A
Original Assignee
Can Fite Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2004/001160 external-priority patent/WO2005063246A1/en
Application filed by Can Fite Biopharma Ltd filed Critical Can Fite Biopharma Ltd
Priority to IL176615A priority Critical patent/IL176615A0/en
Publication of IL176615A0 publication Critical patent/IL176615A0/en

Links

IL176615A 2003-12-29 2006-06-29 Use of an a3 adenosine receptor agonist for the preparation of a pharmaceutical composition for treatment of multiple sclerosis and such pharmaceutical compositions IL176615A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL176615A IL176615A0 (en) 2003-12-29 2006-06-29 Use of an a3 adenosine receptor agonist for the preparation of a pharmaceutical composition for treatment of multiple sclerosis and such pharmaceutical compositions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53271203P 2003-12-29 2003-12-29
PCT/IL2004/001160 WO2005063246A1 (en) 2003-12-29 2004-12-23 Method for treatment of multiple sclerosis
IL176615A IL176615A0 (en) 2003-12-29 2006-06-29 Use of an a3 adenosine receptor agonist for the preparation of a pharmaceutical composition for treatment of multiple sclerosis and such pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL176615A0 true IL176615A0 (en) 2006-10-31

Family

ID=42331267

Family Applications (1)

Application Number Title Priority Date Filing Date
IL176615A IL176615A0 (en) 2003-12-29 2006-06-29 Use of an a3 adenosine receptor agonist for the preparation of a pharmaceutical composition for treatment of multiple sclerosis and such pharmaceutical compositions

Country Status (1)

Country Link
IL (1) IL176615A0 (en)

Similar Documents

Publication Publication Date Title
IL169575A0 (en) Calcium-sensing receptor antagonist compounds and pharmaceutical compositions containing the same
IL165279A (en) Use of alpha-adrenergic agonists and alpha-2a antagonists for the preparation of pharmaceutical compositions for alleviating pain
HK1052653A1 (en) Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
EP1660043A4 (en) Immediate-release formulation of acid-labile pharmaceutical compositions
IL172939A0 (en) Agonist polypeptide of receptor for zot and zonulin and pharmaceutical compositions containing the same
IL171285A (en) Pharmaceutical compositions containing an interleukin- 6 antagonist and uses thereof
HUP0303651A3 (en) N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor and pharmaceutical compositions containing them
GB2394894B (en) New use for pharmaceutical composition
HUP0103558A3 (en) Pharmaceutical composition containing nmda receptor antagonist for the treatment of stroke and traumatic brain insury
IL176519A0 (en) Directly compressible pharmaceutical composition for the oral administration of cci-779
HUP0104406A3 (en) Use of pde v inhibitors for the preparation of pharmaceutical compositions increasing fecundity in mammals
EG24194A (en) 5ht-a-partial agonist pharmaceutical compositions
IL155810A0 (en) Nmda receptor agonist pharmaceutical compositions
IL154057A0 (en) New combination of serotonin agonist (5ht2) and antagonist (5ht6) as pharmaceutical formulation
EP1808446A4 (en) Il-18 receptor antagonist and pharmaceutical composition containing the antagonist
IL163613A (en) Partial or full agonists of a1 adenosine receptors and pharmaceutical compositions comprising the same
IL151369A (en) Use of tgf-beta antagonists for preparation of pharmaceutical compositions
IL161834A0 (en) Pharmaceutical compositions and methods for administering ep2 receptor selective agonists
IL160715A0 (en) Pharmaceutical compositions containing an a1 adenosine receptor antagonist
HUP0303779D0 (en) Pharmaceutical compositions for the treatment of sclerosis multiplex
IL176615A0 (en) Use of an a3 adenosine receptor agonist for the preparation of a pharmaceutical composition for treatment of multiple sclerosis and such pharmaceutical compositions
HUP0200057A3 (en) Dopamine d1 receptor agonist compounds, pharmaceutical compositions containing them and their use
IL174081A0 (en) Formulation for obtaining a pharmaceutical composition, methods of obtaining and use thereof
ZA200603126B (en) Pharmaceutical compositions for therapeutic use
HUP0103049A3 (en) Use of fluexetine for preparation of pharmaceutical compositions